Harmontronics Automation(688022)2025-04-23 14:30Financial Performance - The company's operating revenue for Q1 2025 was ¥191,093,286.46, a decrease of 28.44% compared to ¥267,027,199.05 in the same period last year[4] - Net profit attributable to shareholders was ¥10,799,282.01, down 10.37% from ¥12,049,122.07 year-on-year[4] - The net profit after deducting non-recurring gains and losses increased by 14.17% to ¥11,664,687.80 from ¥10,216,841.48 in the previous year[4] - Net profit for Q1 2025 was ¥10,799,369.72, an increase from ¥8,521,077.40 in Q1 2024, representing a growth of 26.7%[21] - Operating profit for Q1 2025 was ¥16,382,239.50, compared to ¥422,557.06 in Q1 2024, indicating a significant improvement[21] - The company reported a comprehensive income total of ¥10,820,279.09 for Q1 2025, up from ¥8,500,934.07 in Q1 2024, reflecting a growth of 27.3%[22] Cash Flow - The net cash flow from operating activities was ¥38,703,765.04, a significant improvement from a negative cash flow of ¥54,541,794.64 in the same period last year[4] - In Q1 2025, the net cash flow from operating activities was 54.54 million in Q1 2024[25] - Total cash inflow from operating activities in Q1 2025 was 461.09 million in Q1 2024[25] - Cash outflow from operating activities decreased to 515.64 million in Q1 2024, representing a reduction of 60.7%[25] - The net cash flow from investing activities was -2.48 million in Q1 2024[25] - Cash inflow from investing activities decreased to 80.86 million in Q1 2024, a decline of 61.2%[25] - Cash outflow from investing activities was 78.37 million in Q1 2024, a decrease of 21.0%[25] - The net cash flow from financing activities was -9.10 million in Q1 2024[25] - Total cash inflow from financing activities was 451.34 million in Q1 2024[25] - The ending cash and cash equivalents balance for Q1 2025 was 80.08 million in Q1 2024[26] - The company reported a cash decrease of 42.19 million in Q1 2024[25] Research and Development - Total R&D investment was ¥3,648,495.20, a decrease of 82.75% compared to ¥21,156,547.40 in the previous year[5] - R&D investment as a percentage of operating revenue dropped to 1.91%, down 6.01 percentage points from 7.92%[5] - Research and development expenses for Q1 2025 were ¥3,648,495.20, significantly lower than ¥21,156,547.40 in Q1 2024, a decrease of 82.7%[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,844,493,689.40, a decrease of 4.58% from ¥2,980,935,415.04 at the end of the previous year[5] - The company's total assets decreased to ¥2,844,493,689.40 in Q1 2025 from ¥2,980,935,415.04 in Q1 2024, a decline of 4.6%[17] - Total liabilities decreased to ¥2,188,692,232.43 in Q1 2025 from ¥2,338,825,328.86 in Q1 2024, a reduction of 6.4%[17] - The company's equity attributable to shareholders increased to ¥664,539,926.66 in Q1 2025 from ¥650,848,643.58 in Q1 2024, a rise of 2.7%[17] Shareholder Information - The company reported a total of 8,642 common shareholders at the end of the reporting period[10] - The company has a significant shareholder structure, with Suzhou Hanchuan Investment Management Co., Ltd. being the controlling shareholder[12] - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending[13] - There are no significant operational issues or reminders for investors regarding the company's performance during the reporting period[13] Non-Recurring Items - Non-recurring losses totaled ¥865,405.79, primarily due to other operating income and expenses[7]